|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
| Phenotypic Information (metabolism pathway, cancer, disease, phenome) |
| |
| |
| Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG |
| |
|
| Gene Summary for GUCY1B3 |
| Top |
| Phenotypic Information for GUCY1B3(metabolism pathway, cancer, disease, phenome) |
| Cancer | CGAP: GUCY1B3 |
| Familial Cancer Database: GUCY1B3 | |
| * This gene is included in those cancer gene databases. |
|
|
|
|
|
| . | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oncogene 1 | Significant driver gene in | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
| KEGG_PURINE_METABOLISM | |
| Mutations for GUCY1B3 |
| * Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
| - Statistics for Tissue and Mutation type | Top |
![]() |
| - For Inter-chromosomal Variations |
| * Inter-chromosomal variantions includes 'interchromosomal amplicon to amplicon', 'interchromosomal amplicon to non-amplified dna', 'interchromosomal insertion', 'Interchromosomal unknown type'. |
![]() |
| - For Intra-chromosomal Variations |
| * Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. |
![]() |
| Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b |
| breast | GUCY1B3 | chr4 | 156696873 | 156697273 | chr4 | 156885758 | 156886158 | |
| pancreas | GUCY1B3 | chr4 | 156700598 | 156700618 | GLRB | chr4 | 158082577 | 158082597 |
| pancreas | GUCY1B3 | chr4 | 156717766 | 156717786 | ARNT2 | chr15 | 80812678 | 80812698 |
| cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) |
| * From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows GUCY1B3 related fusion information. |
| ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
| Top |
| Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
| Total # sample | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | |||
| GAIN (# sample) | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | |||
| LOSS (# sample) |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
| Top |
|
![]() |
| Top |
| Stat. for Non-Synonymous SNVs (# total SNVs=55) | (# total SNVs=16) |
![]() | ![]() |
(# total SNVs=0) | (# total SNVs=0) |
| Top |
| * When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
| GRCh37 position | Mutation(aa) | Unique sampleID count |
| chr4:156710914-156710914 | p.R116C | 3 |
| chr4:156698728-156698728 | p.F77L | 2 |
| chr4:156725753-156725753 | p.I521M | 2 |
| chr4:156725805-156725805 | p.R539* | 2 |
| chr4:156716530-156716530 | p.S255L | 2 |
| chr4:156710916-156710916 | p.R116R | 2 |
| chr4:156721098-156721098 | p.T349T | 2 |
| chr4:156710952-156710952 | p.G128G | 2 |
| chr4:156721101-156721101 | p.R350R | 2 |
| chr4:156696159-156696159 | p.V39V | 1 |
| Top |
|
![]() |
| Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| # sample | 2 | 2 | 1 | 14 |   |   | 3 |   | 1 | 1 |   | 7 | 3 | 2 |   | 1 | 8 | 9 |   | 5 |
| # mutation | 2 | 2 | 1 | 16 |   |   | 3 |   | 1 | 1 |   | 7 | 3 | 2 |   | 1 | 9 | 10 |   | 7 |
| nonsynonymous SNV | 2 | 1 |   | 15 |   |   | 3 |   | 1 | 1 |   | 5 | 3 |   |   |   | 6 | 8 |   | 6 |
| synonymous SNV |   | 1 | 1 | 1 |   |   |   |   |   |   |   | 2 |   | 2 |   | 1 | 3 | 2 |   | 1 |
| cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
| Top |
| * We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
| Genomic Position | Mutation(aa) | Unique sampleID count |
| chr4:156716530 | p.S187L,GUCY1B3 | 2 |
| chr4:156710914 | p.R48C,GUCY1B3 | 2 |
| chr4:156696161 | p.K57N,GUCY1B3 | 1 |
| chr4:156721098 | p.K116T,GUCY1B3 | 1 |
| chr4:156710933 | p.Y295Y,GUCY1B3 | 1 |
| chr4:156723547 | p.P418L,GUCY1B3 | 1 |
| chr4:156715238 | p.E65A,GUCY1B3 | 1 |
| chr4:156725806 | p.E121Q,GUCY1B3 | 1 |
| chr4:156696163 | p.T298I,GUCY1B3 | 1 |
| chr4:156721099 | p.I453M,GUCY1B3 | 1 |
| * Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
![]() |
| cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
| Top |
| Gene Expression for GUCY1B3 |
| * CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
![]() |
| * Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
![]() |
| Top |
| * This plots show the correlation between CNV and gene expression. |
![]() |
|
![]() |
|
| Top |
| Gene-Gene Network Information |
| * Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
![]() |
| ||||
| CALD1,CCDC102B,CDH6,CHSY3,COL15A1,COL4A1,GPR116, GUCY1A3,GUCY1B3,HEG1,ITGA1,ITGAV,JAZF1,LAMA4, NID1,NID2,NRP1,PCDH17,PRRX1,SH2B3,ZEB2 | CARD8,CDH6,CLIC4,CPNE8,DPY19L1,EIF5A2,EMCN, FLRT2,GUCY1B3,IL33,KCTD12,LBR,LRCH2,MFAP3, PDE1A,DESI2,RAB8B,SEPT7,SGMS1,SGTB,SLFN11 | ||||
![]() |
| ||||
| BNC2,CALD1,CNRIP1,CYYR1,DZIP1,ELOVL4,FBXL7, FERMT2,GUCY1A3,GUCY1B3,LDB2,LPHN2,MPDZ,MSRB3, MYCT1,PABPC5,RHOJ,SGCD,TEK,TSHZ3,ZEB1 | CLMP,BAG2,FEZ1,GUCY1A3,GUCY1B3,LOC644538,LRCH2, PABPC5,PLEKHO1,PLN,PRDM8,PRNP,PTBP2,RAB23, RAB31,RERG,RHOQ,RND2,SCRG1,TMEM55A,ZNF25 |
| * Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
| Top |
| Top |
| Pharmacological Information for GUCY1B3 |
| DB Category | DB Name | DB's ID and Url link |
| * Gene Centered Interaction Network. |
![]() |
| * Drug Centered Interaction Network. |
| DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
| DB00171 | guanylate cyclase 1, soluble, beta 3 | approved; nutraceutical | Adenosine triphosphate | ![]() | ![]() |
| DB00125 | guanylate cyclase 1, soluble, beta 3 | approved; nutraceutical | L-Arginine | ![]() | ![]() |
| DB00155 | guanylate cyclase 1, soluble, beta 3 | approved; nutraceutical | L-Citrulline | ![]() | ![]() |
| DB00435 | guanylate cyclase 1, soluble, beta 3 | approved | Nitric Oxide | ![]() | ![]() |
| Top |
| Cross referenced IDs for GUCY1B3 |
| * We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
|
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |